Long-term course of anti-factor VIII antibody in patients with hemophilia A at a single center

BACKGROUND: Immune tolerance induction (ITI) can reduce inhibitors against factor VIII concentrates by 70-80%. In this study, we elucidated the characteristics of inhibitors and attempted to determine the proper indications and timing for ITI. METHODS: Subjects included hemophilia A patients registe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Ki Young, Joo, Sang Chun, Choi, Yong Mook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828527/
https://www.ncbi.nlm.nih.gov/pubmed/27104190
http://dx.doi.org/10.5045/br.2016.51.1.37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828527/
https://www.ncbi.nlm.nih.gov/pubmed/27104190
http://dx.doi.org/10.5045/br.2016.51.1.37

Ejemplares similares